Numinus Completes First Extraction of its Psilocybe Mushrooms
VANCOUVER, BC, December 17, 2020 – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes. This follows Numinus’ successful completion of […]
Numinus Wellness Announces National Expansion with acquisition of Mindspace Wellbeing
VANCOUVER (December 15, 2020) – Numinus Wellness Inc. (“Numinus” or “Company”) (TSXV: NUMI),a company aimed at creating an ecosystem of health solutions that develops and supports a safe, accessible and evidence-based use of psychedelic-assisted psychotherapies (PAP), is pleased to announce the acquisition of Montreal-based Mindspace Psychology Services Inc.(doing business under the name of Mindbeing, Mind wellbeing) This agreement will bring […]
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
VANCOUVER, BC, Nov. 18, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has announced it will undertake a compassionate access clinical trial of psilocybin-assisted psychotherapy for substance use disorders. This study will […]
Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council
VANCOUVER, BC, Oct. 14, 2020 /CNW/ – Recognized and respected leaders from technology, pharmacology, and health have joined Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI) as members of the Company’s General Advisory Council. Drawing on experience across a broad range of specialities including psychedelic medicine, mental health advocacy, performance optimization, and digital healthcare, the […]
Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
VANCOUVER, BC, Sept. 24, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, is pleased to announce it has begun cultivating Psilocybe mushrooms, for the purpose of psilocybin production, at its 7000 square-foot Health […]
Numinus Announces Closing of Oversubscribed $4.6 Million Offering
Vancouver, British Columbia, September 10, 2020, Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), is pleased to announce that it has closed its previously announced short form prospectus offering, on a best efforts basis, including the exercise of the agent’s option in its entirety in the form of units of the Company (each, a […]
Numinus Announces Filing of Final Short Form Prospectus for Offering of up to $4,000,000
Numinus Wellness Inc. (“Numinus” or the “Company“) (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted therapies, is pleased to announce it has filed a final short form prospectus (the “Prospectus“) dated September 1, 2020 in connection with its previously announced best-efforts offering. […]
Numinus Announces Listing of Warrants
VANCOUVER, BC, Sept. 18, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSXV: NUMI), a company creating an ecosystem of health solutions centred around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapy, is pleased to announce that the TSX Venture Exchange (“TSXV“) has accepted for listing the 9,200,000 warrants (the “Warrants“) […]
Numinus Announces 2020 Operational Plans to Scale
Company gives guidance on near-term business objectives VANCOUVER (May 28th, 2020)— Numinus Wellness Inc. (“Numinus”), recently listed on the TSX Venture Exchange (TSX-V: NUMI), is pleased to report its near-term goals to advance our mission to address the universal desire to heal. For 2020, the company plans to upgrade its lab and processing facilities (for […]
Numinus Wellness Inc. Commences Trading TSX.V:NUMI
VANCOUVER, May 20, 2020 /CNW/ – With momentum building for the use of psychedelic assisted therapies in addressing the growing problems of mental illness, addiction and trauma, Vancouver-based Numinus Wellness Inc. began trading today on the TSX Venture Exchange under the symbol NUMI as one of the first in-market, fully integrated companies in the psychedelic […]